Cigna Corp (CI)
$211.10 0.15 (0.07%)
10:57 EST CI Stock Quote Delayed 15 Minutes
Previous Close $210.95
Market Cap 51.35B
PE Ratio 20.72
Volume (Avg. Vol.) 439,740
Day's Range 209.23 - 211.81
52-Week Range 141.95 - 212.35
Dividend & Yield 0.04 (0.02%)
CI Stock Predictions, Articles, and Cigna Corp News
- From InvestorPlace
- From the Web
When considering these seven companies in 2020, should insider buying be one of your deciding factors? The answer just might be yes.
Tesla ripped to new highs and Nike's been named a Top Pick. Here's what else happened in the stock market today.
These insurance stocks have the potential to deliver in 2020 as they will likely benefit from an improving labor makret and the Fed's decision to keep interest rates constant.
You don't need to avoid healthcare stocks completely. Just be careful where you invest. There's one name Louis Navellier really likes in the space, for example.
Investors saw new highs in the Nasdaq today, but the index finished slightly lower on the day. Here's what we're watching now.
A judge is challenging the CVS Health-Aetna deal and the drug store sector is out of favor. So when will the discount on CVS stock end?
It admittedly takes some guts to step into CVS stock here, in the middle of a renewed legal mess, but that's exactly the time to go bargain hunting.
This rally looks like it still has room to run, and top analysts think these 7 "strong buy" stocks can surge higher.
With the Medicare for All Act threatening to impart a radical paradigm shift, healthcare stocks are suddenly under heavy fire.
Walgreens stock tanked after the company reported weak second-quarter results and issued a light outlook, but there's opportunity here.
Cigna earnings for the fourth quarter of the year included poor 2019 guidance, sending CI stock falling on Friday.
Bears have emerged from hibernation. But not all stocks are suffering their wrath. Here are three healthcare stocks to buy.
With stocks trading at record levels, it can be difficult to identify the best stocks to buy now. Here are 10 picks that the experts have faith in.
Cigna stock will be boosted by the merger of Cigna and Express Scripts Holding Co. In the wake of the deal, CIT stock looks cheap.
Cigna is one step closer to a buyout of ESRX after approval from the Department of Justice. Here's what CI stock investors should expect.
The Daily Biotech Pulse: Novo Nordisk's Ozempic Receives Label Expansion For Cardiovascular Events, Adcom Disappointment Inflicts Pain On Durect Shares
From The Motley Fool
Navellier RatingsPowered by Portfolio Grader